Untitled Document
 
Untitled Document
 
 

Validation of Elispot technology as a surrogate ma
 
관리자 3662 2008-12-29

과제성격 : 노바티스사에서 의뢰 - 단독연구
과제명 : Validation of Elispot technology as a surrogate marker of TB treatment efficacy
기 간 : 2007년 1월 ~ 2008년 12월
책임자 : Eum, Seok-Yong, Ph.D.
기 관 : International Tuberculosis Research Center (ITRC)

요 약 :
The Center shall perform the study entitled “Validation of Elispot technology as a surrogate marker of TB treatment efficacy” (hereinafter called the “Study”) under the terms of this Agreement, such Study to be performed using Elispot diagnostic kits supplied by Novartis for this purpose. The Center is regularly engaged in conducting similar laboratory studies[ and animal tests].

BCG 백신의 특성 조사와 BCG 백신 생산법의 평가
결핵퇴치 2030 계획
 
   
 
 
결핵정보 >국내외 결핵논문  
 
 
Untitled Document